TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Indutrade Life Science AB
Closing information (x1000 EUR)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
1,453
|
434
|
236 |
| Financial expenses |
33
|
27
|
2 |
| Earnings before taxes |
-4,354
|
-3,018
|
-2,052 |
| EBITDA |
-4,331
|
-2,996
|
-2,051 |
| Total assets |
4,971
|
3,341
|
2,262 |
| Current assets |
4,971
|
3,341
|
2,262 |
| Current liabilities |
3,456
|
2,226
|
1,136 |
| Equity capital |
1,515
|
1,116
|
1,126 |
| - share capital |
9
|
9
|
9 |
| Employees (average) |
6
|
6
|
6 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
30.5%
|
33.4%
|
49.8% |
| Turnover per employee |
242
|
72
|
39 |
| Profit as a percentage of turnover |
-299.7%
|
-695.4%
|
-869.5% |
| Return on assets (ROA) |
-86.9%
|
-89.5%
|
-90.6% |
| Current ratio |
143.8%
|
150.1%
|
199.1% |
| Return on equity (ROE) |
-287.4%
|
-270.4%
|
-182.2% |
| Change turnover |
1,034
|
197
|
9 |
| Change turnover % |
247%
|
83%
|
4% |
| Chg. No. of employees |
0
|
0
|
2 |
| Chg. No. of employees % |
0%
|
0%
|
50% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.